Clinical trial
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT01617161 · Massachusetts General Hospital, Other · Active, not recruiting
Key facts
| NCT number | NCT01617161 |
|---|---|
| Title | Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer |
| Official title | Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer |
| Acronym | PARTIQoL |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | University of Pennsylvania National Cancer Institute (NCI) NIH Northwestern Medicine Chicago Proton Center ProCure Proton Therapy Center Washington University School of Medicine University of… |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | Proton Beam Therapy, Intensity Modulated Radiation Therapy |
| Enrollment | 454 |
| Start date | Jul 25, 2012 |
| Primary completion | Dec 1, 2025 |
| Completion | Dec 1, 2030 |
| First posted | Jun 12, 2012 |
| Last update posted | Jan 22, 2026 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: